Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jan 26, 2011

Premium

Integrated Diagnostics announced this week that Kenneth Fang will be its new chief medical officer and VP of translational research and clinical development. In this position, Fang will lead the development of diagnostics for the early detection of complex diseases, such as lung cancer and Alzheimer’s disease. Previously, Fang served as senior director for clinical development at XDx and was on the faculty at University of California - San Francisco.


23andMe this week announced it has formed an Independent Sarcoma Scientific Advisory Committee. In the committee, 23andMe has appointed Robert Maki, a medical oncologist and co-leader of the adult sarcoma disease management team at Memorial Sloan-Kettering Cancer Cetner; George Demetri, director of Dana-Farber Cancer Institute's Center for Sarcoma and Bone Oncology; Judy Garber, co-director of the Friends of Dana-Farber Cancer Genetics and Prevention Program; and Mark Robson, clinic director, of Sloan-Kettering's Clinical Genetics Service; and others.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.